Basit öğe kaydını göster

Intravitreal Lower- Dose (20 mu g) Melphalan for Persistent or Recurrent Retinoblastoma Vitreous Seeds

dc.contributor.authorBalci, Ozlem
dc.contributor.authorKebudi, Rejin
dc.contributor.authorTuncer, Samuray
dc.contributor.authorTanyildiz, Burak
dc.contributor.authorShields, Carol L.
dc.date.accessioned2021-03-02T22:07:02Z
dc.date.available2021-03-02T22:07:02Z
dc.date.issued2015
dc.identifier.citationTuncer S., Balci O., Tanyildiz B., Kebudi R., Shields C. L. , "Intravitreal Lower- Dose (20 mu g) Melphalan for Persistent or Recurrent Retinoblastoma Vitreous Seeds", OPHTHALMIC SURGERY LASERS & IMAGING RETINA, cilt.46, sa.9, ss.942-948, 2015
dc.identifier.issn2325-8160
dc.identifier.otherav_0ad60335-5ed3-4aea-8468-c9fca877e945
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/12999
dc.identifier.urihttps://doi.org/10.3928/23258160-20151008-07
dc.description.abstractBACKGROUND AND OBJECTIVE: The major cause of failure in the management of retinoblastoma is the persistence/recurrence of vitreous seeds (VS). This study reports the efficacy and complications of standard lower-dose (20 mu g) intravitreal melphalan for VS.
dc.language.isoeng
dc.subjectTıp
dc.subjectGöz Hastalıkları ve Cerrahisi
dc.subjectSağlık Bilimleri
dc.subjectCerrahi Tıp Bilimleri
dc.subjectCERRAHİ
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectOFTALMOLOJİ
dc.titleIntravitreal Lower- Dose (20 mu g) Melphalan for Persistent or Recurrent Retinoblastoma Vitreous Seeds
dc.typeMakale
dc.relation.journalOPHTHALMIC SURGERY LASERS & IMAGING RETINA
dc.contributor.departmentİstanbul Medipol Üniversitesi , ,
dc.identifier.volume46
dc.identifier.issue9
dc.identifier.startpage942
dc.identifier.endpage948
dc.contributor.firstauthorID225060


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster